Covid-19 Drugs

COVID-19 News: U.S. FDA Halts Usage Of Bebtelovimab To Treat COVID-19 As Drug Is Not Able To Neutralize New SARS-CoV-2 Variants And Sub-Lineages!

COVID-19 News - Bebtelovimab Dec 01, 2022 2 years ago

COVID-19 News: The U.S. FDA issued an announcement in the last 24 hours stating that Bebtelovimab is not currently authorized in any U.S. region to treat COVID-19. According to the announcement, the predominant variants in circulation that includes the BQ.1 and BQ.1.1 variants ad sub-lineages can no longer be neutralized by the monoclonal antibody drug Bebtelovimab that is made by ph...

BREAKING COVID-19 News: Researchers Warn That Molnupiravir Is Driving Rapid Evolution Of SARS-CoV-2 Variants And Causing Mutations!

COVID-19 News - Molnupiravir Nov 30, 2022 2 years ago

COVID-19 News: When Thailand Medical News in September 2021 warned about the dangers of the US FDA approved drug Molnupiravir to treat COVID-19, our news coverage was not taken seriously as most Westerners always think that only the media in their own countries that is funded by crooked politicians, unethical billionaires, greedy pharma giants and those controlling the COVID-19 narratives are the ...

Canadian Study Finds That Interferon Lambda Helps In Rapid Clearance Of SARS-CoV-2 Even In Age-Related Delays In The Induction Of T Cell Immunity!

COVID-19 News - Interferon Lambda Nov 19, 2022 2 years ago

COVID-19 News: A new breakthrough study by Canadian researchers from the University of Manitoba, University of Toronto, Canada University Health Network and University of Alberta, Edmonton has found that treating SARS-CoV-2 infected individuals with interferon Lambda helps in rapid clearance of the virus even in those with age-related delays in the induction of T cell immunity! This new t...

BREAKING! Egyptian Randomized Clinical Trial Shows That Inhalable Sodium Bicarbonate Could Be Used As Adjuvant In COVID-19 Treatment Protocols!

Source: COVID-19 News - Inhalable Sodium Bicarbonate As An Adjuvant For COVID-19 Nov 19, 2022 2 years ago

COVID-19 News: A randomized clinical trial conducted by researchers from the Faculty of Medicine, Mansoura University - Egypt has found that inhalable sodium bicarbonate could be used as adjuvant in COVID-19 prophylactic and treatment protocols! Most COVID-19 News outlets have not been covering on the various clinical trials involving cheaper repurposed drugs or compounds that can be used...

Yet Another Study, This Time Led By Scientists From The University of Minnesota Shows That Metformin Decreases Risk Of COVID-19 Severity!

Source: COVID-19 Drugs - Metformin Nov 18, 2022 2 years ago

COVID-19 Drugs: Study findings from yet another research led by scientists from the University of Minnesota Medical School has added to the growing evidence that metformin, a common and cheap generic diabetic drug is able to decrease the risk of COVID-19 severity. Thailand Medical News had previously covered on various past studies that showed metformin not only reduced the risk of COVID-...

BREAKING! Spanish Scientists Claim That Cheap Natural Cyclodextrins Especially Beta Cyclodextrins Can Be Used As Antivirals Against SARS-CoV-2!

Source: COVID-19 News - Cyclodextrins - SARS-CoV-2 - Antivirals Nov 17, 2022 2 years ago

COVID-19 News: A new study by researchers from Spain led by scientist from the Cell Structure Lab, Centro Nacional de Biotecnologia, CNB - CSIC, Campus de Cantoblanco, Madrid -Spain has found that cheap natural cyclodextrins especially Beta Cyclodextrins can be used as antivirals against SARS-CoV-2! Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of...

Utah Study Validates That Selective Serotonin Reuptake Inhibitors (SSRIs) Such As Fluoxetine Or Fluvoxamine Do Not Reduce COVID Severity

Source: COVID-19 Drugs - Fluvoxamine Nov 07, 2022 2 years ago

COVID-19 Drugs: A new study by researchers from Intermountain Medical Center; Stanford, Salt Lake City-Utah, USA has confirmed that the usage of selective serotonin reuptake inhibitors (SSRIs) such as Fluoxetine or Fluvoxamine does not reduce COVID Severity. Shockingly, the study findings showed that hospitalization and death were significantly greater in the those taking SSRIs such as Fluoxetine...

Californian Researchers Modify Generic Drug Memantine To Inhibit SARS-CoV-2 And Treat COVID-19 Issues

Source: COVID-19 Drugs - Memantine - NMT5 Nov 02, 2022 2 years ago

COVID-19 Drugs: Researchers from Scripps Research Institute - California-USA have created a variant of the generic drug Memantine which is an Aminoadamantane compound, to inhibit the SARS-CoV-2 virus entry by targeting the ACE2 receptors. Prevention of infection and propagation of the SARS-CoV-2 coronavirus is a high priority in the ongoing COVID-19 pandemic which is expected to get worse...

BREAKING! Taiwanese Study Shows Inhaled Ciclesonide Reduces Risk Of Mortality And Need For Mechanical Ventilation In Hospitalized COVID-19 Patients

Source; COVID-19 Drugs -Inhaled Ciclesonide Oct 30, 2022 2 years ago

COVID-19 Drugs: A new study by researchers from the Division of Pulmonary and Critical Care Medicine at MacKay Memorial Hospital- Taiwan has found that the usage of inhaled Ciclesonide reduces risk of mortality and need for mechanical ventilation in hospitalized COVID-19 patients. Thailand Medical News had already reported as early as August 2020 about the possible prophylactic and also t...

BREAKING! Lectins From Bananas Could Serve As An Antiviral Against The SARS-CoV-2 Coronavirus Including Emerging Omicron Sub-lineages!

Source: COVID-19 News - Banana Lectin H84T As A SARS-CoV-2 Antiviral Oct 21, 2022 2 years ago

COVID-19 News: A new study conducted by researchers from University of Hong Kong – China, Johannes Kepler University Linz, Linz – Austria and the University of Michigan, Ann Arbor-USA has found that lectins derived from bananas could serve as effective antivirals against the SARS-CoV-2 virus including against the Omicron variant. As early as 2020, Thailand Medical News has cov...

BREAKING! Leading Cardiologists And Doctors From Massachusetts Issue Warning Of Adverse Drug Interactions In COVID-19 Patients Treated With Paxlovid!

Source: COVID-19 Drugs - Paxlovid Oct 13, 2022 2 years ago

COVID-19 Drugs: Leading cardiologists and physicians from various hospitals and medical centers across the state of Massachusetts-USA have issued a warning of adverse drug interactions especially involving heart medications in COVID-19 patients treated with Paxlovid (Nirmatrelvir/Ritonavir). The team of specialists from Lahey Hospital and Medical Center, Brigham and Women’s Hospital...

BREAKING! Wuhan Study Shows That Glutamine And Pyruvate Supplementation, Also Rosiglitazone Can Reduce And Prevent Hyperinflammation In COVID-19!

Source: COVID-19 Drugs -Glutamine, Pyruvate, Rosiglitazone, Arginine, 2-DG Oct 11, 2022 2 years ago

COVID-19 Drugs: A new breakthrough study by researchers from the Zhongnan Hospital of Wuhan University-China and Southern University of Science and Technology, Shenzhen-China has found that glutamine and pyruvate supplementation, and also the drug diabetic drug Rosiglitazone can reduce and prevent cytokine upregulation hyperinflammation as result of inflammation in macrophages induced by the SARS-...

Spanish Study Shows That Metformin (Glucophage) Lowers Risk Of Disease Severity And Fatal Outcomes In Diabetic Patients Infected With COVID-19

Source: COVID-19 Drugs - Metformin Oct 11, 2022 2 years ago

COVID-19 Drugs: Spanish researchers and physicians have in a new study found that the diabetic drug Metformin (Glucophage) lowers the risk of disease severity and fatal outcomes in diabetic patients infected with the SARS-CoV-2 coronavirus. The study involved medical researchers from the Hospital Clinic of Barcelona-Spain, Universitat Autònoma de Barcelona-Spain and Fundació Institu...

U.S. FDA Issues Warning To Healthcare Professionals That Evusheld Is Not Effective Against Newer Variants And Soon To Issue Another Regarding Bebtelovimab!

Source: COVID-19 Drugs - Evusheld - Bebtelovimab Oct 04, 2022 2 years ago

COVID-19 Drugs: Thailand Medical News has been warning since the last two weeks that we are entering a very dangerous phase of the COVID-19 pandemic, one in which not only are we are going to be faced with an onslaught of more than 30 to 50 circulating new Omicron sub-lineages that are more transmissible and immune evasive but also more pathogenic. Reinfections and Co-infections are going to be th...

Thai Study Shows That Povidone-Iodine Nasal Sprays Are Not the Least Effective As A Prophylaxis To Prevent SARS-CoV-2 Infections

Source: Medical News - Povidone Nasal Sprays For COVID-19 Aug 24, 2022 2 years ago

A study by researchers from Mahidol University, Siam University and Samut Sakhon Hospital has found that 0.4% povidone-iodine nasal spray is not the least effective as a prophylaxis to prevent SARS-CoV-2 infections. During the initial phases of the SARS-CoV-2 pandemic, numerous Indian scammers and Indian run companies were promoting various Povidone-iodine nasal sprays products as prophyl...

University Of Minnesota Led Phase Three Randomized Clinical Trial Shows That Metformin Reduces Risk Of COVID-19 Disease Severity And Mortality.

Source: Medical News - COVID-19 Drugs - Metformin Aug 22, 2022 2 years ago

COVID-19 Drugs: A randomized clinical trial involving 1431 non-hospitalized patients showed that metformin reduced the risk of COVID-19 severity and risk of COVID-19 mortality. The randomized double-blinded placebo- controlled trial by conducted by the COVID-OUT consortium that is led by researchers from University of Minnesota and also involved medical scientists from the UnitedHealth Gro...

BREAKING! Japanese Study Finds U.S. FDA Approved And Promoted COVID-19 Drug Remdesivir Induces Cardiomyocyte Dysfunction And Is Cardiotoxic!

Source: Medical News - COVID-19 Drugs -Remdesivir Aug 13, 2022 2 years ago

COVID-19 Drugs: A new study by Japanese researchers from Tohoku University, Kyushu University, Okayama University and the National Institutes of Natural Sciences, Okazaki-Japan has alarmingly found that the U.S. FDA approved and heavily promoted drug for COVID-19 ie Remdesivir activates the urotensin II receptor and induces cardiomyocyte dysfunction that can lead to heart issues that can also end ...

World Health Organization Issues Warning Against The Use Of Fluvoxamine And Colchicine To Treat COVID-19

Source: COVID-19 Drugs Jul 14, 2022 2 years ago

COVID-19 Drugs: The World Health Organization has strongly advised against the usage of two drugs to treat non-severe COVID-19, ie the antidepressant drug fluvoxamine and the gout drug colchicine. The WHO said that both drugs were not recommended for patients with mild or moderate COVID-19 because there is currently insufficient evidence that they improve important outcomes for patients, and both...

BREAKING! Stanford Study Shows That Aldactone, A Potassium Sparing Diuretic Drug Improves COVID-19 Clinical Outcomes.

COVID-19 Drugs - Spironolactone (Aldactone) Jul 08, 2022 2 years ago

COVID-19 Drugs: A new study by medical researchers from Stanford University-California has found that the commonly available and cheap generic drug, Spironolactone (Aldactone) improves clinical outcomes especially in severe COVID-19 infections. Spironolactone, sold under the brand name Aldactone among others, is a medication that is primarily used to treat fluid build-up due to heart failure, liv...

BREAKING! Pfizer Has Stopped Enrollment For Its So Called SARS-CoV-2 Antiviral Drug Paxlovid Trial in Standard-Risk Population

Source: COVID-19 Drugs-Paxlovid Jun 16, 2022 3 years ago

In a surprising move, the American big pharma company that is a major supporter of the Biden administration…Pfizer Inc on Tuesday announced that it would halt enrollment in a clinical trial for its claimed COVID-19 antiviral COVID-19 drug-Paxlovid, in standard-risk patients after data analysis showed a non-significant reduction in hospitalizations and deaths. Typically, the standar...

LATEST! Danish Study Shows That Mutations E166V and L50F+E166V On SARS-CoV-2 Variants Weakens Nirmatrelvir (A Component Of Paxlovid) Mpro Binding!

Source: COVID-19 Drugs - Nirmatrelvir & Paxlovid Jun 10, 2022 3 years ago

COVID-19 Drugs: A new study by researchers from the Copenhagen University Hospital-Denmark, the Department of Immunology and Microbiology at the University of Copenhagen-Denmark and the Technical University of Denmark has found that the mutations E166V and L50F+E166V that are found on various emerging SARS-CoV-2 variants, weakens nirmatrelvir-Mpro binding. Nirmatrelvir, an oral protease inhibitor ...

French Study Shows That The Antibiotic Clofoctol Could Be Repurposed To Treat COVID-19

Source: COVID-19 Drugs - Clofoctol May 30, 2022 3 years ago

COVID-19 Drugs: A new study by researchers from the University of Lille-France, the Institut Pasteur de Lille-France, the Center for Infection and Immunity of Lille-France, CNRS, INSERM, and CHU Lille0France has found that the existing antibiotic Clofoctol could be repurposed to treat COVID-19. Clofoctol is a bacteriostatic antibiotic. It is used in the treatment of respiratory tract and ear, nos...

British Study Shows That Viagra Can Be Used To Treat COVID-19 Related Pneumonitis And Moderate To Severe ARDS!

Source: COVID-19 Drugs - Viagra - Sildenafil May 18, 2022 3 years ago

COVID-19 Drugs: A new study by researchers from the University College London-UK, Imperial College London and the Royal Brompton Hospital-UK has found that the drug Viagra can be used to treat COVID-19 related pneumonitis and moderate to severe ARDS. Sildenafil, sold under the brand name Viagra among others, is a medication used to treat erectile dysfunction and pulmonary arterial hyperte...

Indian Study Adds More Evidence That The Asthma Drug Montelukast (Singulair) Can Inhibit SARS-CoV-2 Replication And Is A Potential COVID-19 Drug!

Source: COVID-19 Drugs - Montelukast Apr 28, 2022 3 years ago

COVID-19 Drugs: Researchers from the Indian Institute of Science, India has found that the asthma drug Montelukast (Singulair) can block the SARS-CoV-2 non-structural protein 1 (Nsp1,) which in turn results in the inhibition of SARS-CoV-2 replication, showing it prowess as potential COVID-19 drug! Montelukast is a drug used in the maintenance treatment of asthma that is marketed under the trade n...

BREAKING! China Starts Using The Antibiotic Minocycline That Also Has Antiviral Properties To Treat COVID-19

Source: SARS-CoV-2-Minocycline Apr 23, 2022 3 years ago

SARS-CoV-2-Minocycline: News has emerged that China is now using the antibiotic drug Minocycline to treat COVID-19 cases in various cities across China including Shanghai despite lack of published clinical trial studies showing its efficacy. Chinese researchers from the Chinese Academy of Medical Sciences & Peking Union Medical College along with scientists from the Inner Mongolia Medical Un...

Urgent Studies Needed On Paxlovid! Does It Only Help Alleviate Symptoms And Suppress Viral Load For A While But Does Not Help In Total Viral Clearance?

Source: COVID-19 Drugs - Paxlovid Apr 20, 2022 3 years ago

We at Thailand Medical News think that urgent studies are needed by independent and credible researchers with regards to Pfizer’s Paxlovid as there are many now many unpublished case reports by both physicians and also patients reporting anomalies when the so-called antiviral drug is used to treat COVID-19 patients. One common occurrence being reported is that many when tested posit...

Breaking! SARS-CoV-2 Dysregulates One-Carbon Metabolism In Human Host With Implications For Various Long Term Diseases! N-Acetyl Cysteine Helps!

Source: Medical News - NAC Apr 14, 2022 3 years ago

Yet another worrisome study finding has emerged that adds to the growing list of human host cellular and biological pathways… now numbering in hundreds, that are dysregulated or disrupted by the SARS-CoV-2 coronavirus with implications for long term medical and health issues, some that can end up with fatal outcomes. Already Thailand Medical News has issued numerous warnings that m...

Most Who Have Been Exposed To The Proteins Of The SARS-CoV-2 Virus Will Have Shortened Lifespans! Stop Using Fluvoxamine For BA.2 Infections!

Source: Thailand Medical Apr 01, 2022 3 years ago

No this is not some April Day prank nor it is some fear porn to get everyone anxious, rather this is stark warning that everyone who has been exposed to the proteins of the SARS-CoV-2 virus through whichever means need to take it upon themselves to do frequent medical checkups and also to take necessary precautions and also to seek out treatment protocols to self-treat themselves as even the...

George Washington University Cohort Study Shows That Aspirin Reduces Mortality Rates In Hospitalized Patients With Moderate COVID-19

Source: COVID-19 Drugs - Aspirin Mar 25, 2022 3 years ago

COVID-19 Drugs: A new cohort study by researchers from George Washington University-USA has demonstrated that aspirin use is associated with reduced risk of mortality in hospitalized moderate COVID-19 patients. Previous observational studies already showed that aspirin use may be associated with reduced mortality in high-risk hospitalized patients with COVID-19, but aspirin’s effica...

BREAKING! Cold Spring Harbor Phase 2 Clinical Trial Shows That Famotidine Is Effective In Treating COVID-19 Especially In Mild To Moderate Cases!

Source: COVID-19 Drugs - Famotidine Mar 02, 2022 3 years ago

COVID-19 Drugs: The study findings of a phase 2 clinical trial led by Feinstein Institutes for Medical Research-New York and Cold Spring Harbor Laboratory shows that the common heart burn drug Famotidine is effective in treating COVID-19 disease especially for those with in mild to moderate cases. It should be noted that Thailand Medical News first reported on the potential of using famot...

Fake Molnupiravir Pills From Mexico And India Flooding Black Markets Around The World

Source: Pharma News Feb 06, 2022 3 years ago

Pharma News: Fake molnupiravir pills under a variety of brandnames are appearing not only on various illegal online sites that are selling controlled medications but also in many pharmacies around the world that are known to also sell controlled drugs illegally and also in the various notorious drug ‘black-market retail sites’. It was reported that only after a week in January when mo...

Brown University-Rhode Island Scientists Finds That Chitinase 3-Like-1 (CHI3L1) Inhibitors Stops Replication Of SARS-CoV-2 Including Omicron In Human Host

Source: COVID-19 Drugs-Kasugamycin-FRG Jan 30, 2022 3 years ago

COVID-19 Drugs: Scientists from Brown University-Rhode Island have found that that Chitinase 3-Like-1 (CHI3L1) inhibitors stops replication of the SARS-CoV-2 coronavirus including the Omicron and Delta variants in the human host. Chitinase-3-like protein 1 (CHI3L1), also known as YKL-40, is a secreted glycoprotein that is approximately 40kDa in size that in humans is encoded by the CHI3L1 g...

Austrian Study Shows Calcium Channel Inhibitors Including Amlodipine, Nifedipine, Felodipine And The Phytochemical Neferine Can Treat COVID-19 Infections

Source: Calcium Channel Inhibitors-SARS-CoV-2 Jan 20, 2022 3 years ago

Calcium Channel Inhibitors-SARS-CoV-2: A new study by researchers from the Institute of Biophysics, Johannes Kepler University Linz-Austria has found that calcium channel inhibitors including existing drugs such as amlodipine, nifedipine, felodipine, verapamil and the phytochemical neferine from the lotus plants can possibly treat SARS-CoV-2 infections. Strategies for inhibition of cellular ...

BREAKING! Californian Study Shows That SARS-CoV-2 Infections Can Be Controlled By Inhibiting Human Host SIRT5. SIRT5 Inhibitors As Potential COVID-19 Drugs

Source: SIRT5 Inhibitors As Potential COVID-19 Drugs Jan 11, 2022 3 years ago

A new study by researchers from Buck Institute for Research on Aging-California, Gladstone Institute-California, University of California-San Francisco and the QBI COVID-19 Research Group (QCRG)-California has revealed that the SARS-CoV-2 coronavirus can be inhibited and controlled by downregulating human host SIRT5. The study findings showed that SIRT5 is a proviral factor and that SARS-CoV-2 lev...

Study Shows Ramatroban, A Thromboxane A2 & Prostaglandin D2 Receptor Antagonist Can Be Used To Treat COVID Respiratory Distress And Hypoxemia

Source: COVID-19 Drugs - Ramatroban Jan 03, 2022 3 years ago

COVID-19 Drugs: A small clinical study conducted by researchers from the Charak Foundation-California-USA, Regulatory Wisdom-India, the EyeSight Eye Hospital and Retina Centre-India and the University of California Irvine-USA has found that the drug Ramatroban, which is a thromboxane A2 & prostaglandin D2 receptor antagonist can be used to treat COVID respiratory distress and hypoxem...

BREAKING! Latest German Study Reinforces Past Research Showing Iota-Carrageenan Ability To Inhibit Replication Of All SARS-CoV-2 VOCs.

Source: COVID-19 Prophylactics-Therapeutics Dec 14, 2021 3 years ago

COVID-19 Prophylactics-Therapeutics: Scientist from Friedrich-Alexander University Erlangen-Nürnberg-Germany, Ulm University Medical Center-Germany, University Hospital Tübingen-Germany and Marinomed Biotech AG-Austria have in a new study found that the safe and non-toxic natural compound iota-carrageenan has the ability to inhibit replication of all existing SARS-CoV-2 variants of ...

BREAKING! Cornell Study Find That Entry Of Coronaviruses Is A Ca2+-Dependent Process. Calcium Channel Blockers Could Be Potential COVID-19 Drugs

Source: COVID-19 Drugs - Calcium Channel Blockers Dec 12, 2021 3 years ago

COVID-19 Drugs: A new study by researchers from Cornell University -New York has found that that entry of coronaviruses such as SARS-1, MERS and even SARS-CoV-2 is a Ca2+-dependent process. The study findings also propose that existing FDA approved calcium channel blockers could be repurposed as potential COVID-19 drugs. We are making a special appeal to all readers to please help to sustain this...

BREAKING! Scientists Find That The OTC Drug Diphenhydramine When Paired With Lactoferrin Could Be A New Therapeutic For COVID-19

Source: COVID-19 Drugs Dec 09, 2021 3 years ago

COVID-19 Drugs: A new study by scientists from the University of Florida-USA and the University of Saskatchewan has found that the common over-the-counter antihistamine diphenhydramine when paired with the commonly available supplement lactoferrin, a protein found in cow and human milk, the pair had the capability to hinder the SARS-CoV-2 virus during tests in monkey cells and ...

Much Touted Merck’s COVID-19 Drug-Molnupiravir Shown To Be Less Effective In New Analysis. Experts Question Its Efficacy Against The Omicron Variant

SourceL COVID-19 Drugs - Molnupiravir Dec 05, 2021 3 years ago

COVID-19 Drugs: Updated data on molnupiravir shows the drug reduces hospitalization or death by 30%, down from the initially reported 50% efficacy. Last week Merck has provided updated data on its COVID-19 antiviral, molnupiravir, that shows the antiviral to be significantly less effective against the virus than previously thought. https://www.merck.com/news/merck-and-ridgeback-biotherapeutics-p...

BREAKING! Stanford Study Confirms Favipiravir Use In Mild Or Asymptomatic COVID-19 Patients Has No Efficacy. Doctors Should Be Sued For Prescribing It!

Source: COVID-19 Drug Scams-Favipiravir Nov 29, 2021 3 years ago

Since the beginning of the pandemic, certain countries like China and Japan were advocating the use of Favipravir (Avigan) to treat COVID-19 despite lack of evidence to show its efficacy. Surprisingly, although China was advocating its use to other countries by giving and selling stocks of the drug, it was never really endorsed in its own national guidelines for COVID-19 treatment neither was it u...

Study Shows Potential Of Combining Iota-Carrageenan And Xylitol As A Potential Prophylactic Nasal Spray For COVID-19

Source: COVID-19 Prophylactics-Therapeutics Nov 26, 2021 3 years ago

COVID-19 Prophylactics-Therapeutics: Researchers from the University of Tennessee Health Science Center-USA and Instituto de Ciencia y Tecnología-Argentina have in a new study demonstrated that a combination of iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture, paving the way for the development of a prophylactic and therapeutic nasal spray for COVID-19. Since the...

University of California And Stanford Study Shows SSRI Antidepressants Like Fluoxetine Or Fluvoxamine Lowers Risk Of COVID-19 Mortality

Source: COVID-19 Drugs Nov 16, 2021 3 years ago

COVID-19 Drugs: University of California-San Francisco and Stanford University researchers have in a new study involving the meta-analysis of health records from 87 health care centers across America found that individuals taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), especially Fluoxetine or Fluvoxamine were significantly less likely to die of COVID-19 ...

Study Reveals That Low Low-Molecular-Weight Heparin Curtails Duration Of SARS-CoV-2 Infection Besides Reducing Disease Severity And Risk Of Mortality

Source: Medical News-COVID-19 Drugs Nov 14, 2021 3 years ago

COVID-19 Drugs: A new study by Austrian researchers from the Medical University of Vienna, Kaiser Franz Josef Hospital, University of Innsbruck and the Johannes Kepler University-Austria has found that not only does the anticoagulant-low molecular weight Heparin reduces the risk of disease severity and mortality about those with COVID019 but it also curtails the duration of the SARS-CoV-2 Infectio...

China’s Medical Researchers Exploring Hydrogen Therapy (Both Gaseous Inhalation And Hydrogen Water) For COVID-19

Source: COVID-19 Treatments - Hydrogen Nov 13, 2021 3 years ago

COVID-19 Treatments: Researchers from Tianjin Medical University General Hospital-China and Weifang Medical University-China are exploring the usage of hydrogen therapy as a possible adjuvant treatment for COVID-19. COVID-19 is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment to date except ...

COVID-19 Drug Breakthrough! South Korean Study Demonstrates Potential Of Using Hemin To Treat COVID-19 Via Heme Oxygenase-1 Induction

Source: COVID-19 Drugs Nov 09, 2021 3 years ago

COVID-19 Drugs: A new COVID-19 drug breakthrough study led by researchers from the Department of Infectious Diseases, Konkuk University-Gwangjin-gu-South Korea along with help from Chung-Ang University- Gyeonggi-South Korea has demonstrated that the pharmaceutical product called Hemin can be used to treat COVID-19 via heme oxygenase-1 Induction. The antiviral effects of heme oxygenase-1 (HO-1), a...

BREAKING! Australia Now Turning To Oysters As A Cure For COVID-19! Cavortin A Compound Found In Oysters Could Be A Potential SARS-CoV-2 Antiviral!

Source: SARS-CoV-2 Antivirals Nov 08, 2021 3 years ago

SARS-CoV-2 Antivirals: Maybe as a result of an oversupply of Pacific oysters due to a trade spat with China, Australians are desperate to find alternative uses for their oysters or maybe there is some scientific basis after all since a study has been published in the peer reviewed journal: Reviews In Medical Virology, showing the possible benefits of hemoplymph from Pacific oysters (Crassostrea gi...

The TOGETHER Randomized Clinical Trials Shows That Fluvoxamine Reduces Risk Of COVID-19 Disease Severity And Reduces Need For Hospitalization

Source: COVID-19 Drugs Oct 28, 2021 3 years ago

Fluvoxamine-COVID-19: The results from the TOGTHER clinical trial has shown that fluvoxamine reduces the risk of COVID-19 disease severity and reduces the need for hospitalization. The TOGETHER trial is a randomized, adaptive platform trial to investigate the efficacy of repurposed treatments for COVID-19 disease among high-risk adult outpatients. The trial was designed and done in partner...

German Researcher Highlights The Importance Of Autophagy In Fighting SARS-CoV-2 Infections And Identifies Drugs That Could be Repurposed To Treat COVID-19

Source: Autophagy-SARS-CoV-2 Oct 26, 2021 3 years ago

Autophagy-SARS-CoV-2: A review published by a researcher, Dr Theo Rein from the Max Planck Institute of Psychiatry, Munich-Germany in the peer reviewed Journal of Cellular Biochemistry highlights the importance of autophagy in the fight against SARS-CoV-2 infections and also identifies potential drugs that could be repurposed to treat COVID-19. https://onlinelibrary.wiley.com/doi/10.1002/jcb.30166...

Danish, Canadian & Italian Researchers Finds That The Antimicrobial Drug Atovaquone Has Antiviral Potential Against SARS-CoV-2 & Emerging VOCs!

Source: COVID-19 Drugs Oct 25, 2021 3 years ago

COVID-19 Drugs: A new multinational research involving medical scientists from Aarhus University-Denmark, Istituto Pasteur Italia-Cenci Bolognetti Foundation-Italy, University of Ottawa-Canada and Ottawa Hospital Research Institute-Canada has found that the U.S, FDA approved antimicrobial drug Atovaquone has antiviral potential against the SARS-CoV-2 coronavirus and emerging VOCs and could be repu...

Study Shows That Use of Antithrombotics Such As Aspirin And Apixaban Does Not Help Non-Hospitalized COVID-19 Patients With Mild Or Moderate Symptoms

Source: Antithrombotics-COVID-19 Oct 21, 2021 3 years ago

Antithrombotics-COVID-19: A new multi-institutional clinical study has shown that antithrombotic therapy involving drugs like aspirin or apixaban is not warranted in COVID-19 outpatients. The researchers from Brigham and Women’s Hospital-Massachusetts, University of Pittsburgh-Pennsylvania, University of Illinois-Chicago, Intermountain Healthcare-Utah, National Heart, Lung, and Blood Instit...

Penn State Study Shows That Glucose-Regulating Drugs Like GLP-1R Agonists, DPP-4 Inhibitors & Pioglitazone Reduces Risk Of COVID-19 Severity

Source: COVId-19 Drugs Oct 20, 2021 3 years ago

COVID-19 Drugs: A new multinational retrospective cohort study by researchers from Penn State College of Medicine, Pennsylvania-USA shows that glucose-regulating medications used to treat obesity and type-2 diabetes may improve outcomes in COVID-19 patients with type-2 diabetes. It has already been known that individuals with type 2 diabetes mellitus (T2DM) are at increased risk of severe COVID-1...

New American Study Shows That The Antiemetic Drug Zofran Lowers Risk Of Mortality Of Severe COVID-19 Patients On Ventilators

Source: COVID-19 Drugs Oct 15, 2021 3 years ago

COVID-19 Drugs: A new study that analyzes real-world data utilizing artificial intelligence by researchers from AdventHealth Research Institute-Orlando, Oak Ridge National Laboratory-Tennessee and the University of Tennessee has found that the antiemetic drug Zofran (Ondansetron) lowers risk of mortality of severe COVID-19 patients on ventilators and is associated with increased survival of these ...

Hilarious! Study Confirms Monoclonal Antibody Treatments Are Driving Emergence Of Antibody Resistant Variants But Corrupted US Agencies Are Promoting Them!

Source: Monoclonal Antibodies-SARS-CoV-2 Variants Oct 07, 2021 3 years ago

Monoclonal Antibodies-SARS-CoV-2 Variants: If anything, the COVID-19 pandemic has revealed to those intelligent enough to understand anything that the elites in the United States are nothing more than the most filthy, unethical and greedy and corrupted live forms ever to emerge this earth. From day one of the pandemic, certain American elites have been controlling the narratives of the COV...

Molnupiravir - What's Wrong With America? Why Is the American Government And Agencies Funding And Pushing Potentially Toxic Drugs To Treat COVID-19?

Source: COVID-19 Exposé Sep 24, 2021 3 years ago

COVID-19 Exposé : First it was the Trump Administration along with the U.S.NIH or to be specific the NIAID headed by Anthony Fauci that poured millions of dollars in to the development and research of the overpriced drug remdesivir that is not only hepatoxic but also nephrotoxic to treat COVID-19. There are tons of studies that confirm its toxicity issues, these are just a few. http...

Researcher Proposes Using Aprepitant As A Drug To Target Neurokinin-1 Receptors To Prevent COVID-19 Cytokine Storms

Source: COVID-19-Drugs Sep 22, 2021 3 years ago

COVID-19 Drugs: A researcher from the University of Lahore Pakistan has proposed that the drug aprepitant could be used to target the neurokinin-1 receptors to prevent COVID-19 cytokine storms. Aprepitant is a medication used in the management and treatment of chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV). It is in the neurokinin-1 a...

Interesting Reads

SARS-CoV-2 XEC Variant Shows Enhanced Immune Evasion through NTD Glycosylation

Nikhil Prasad
Oct 24, 2024 2 months ago

Many exposed to COVID-19 will develop Acute Ischemic Colitis!

Nikhil Prasad
Oct 21, 2024 2 months ago

Breaking News! Study Reveals Potential New Form of Brain Neurodegeneration Linked to COVID-19!

Nikhil Prasad
Oct 02, 2024 3 months ago

Word-Finding Challenges Linked to Post-COVID-19 Syndrome

Nikhil Prasad
Oct 02, 2024 3 months ago

Italian study discovers new subtype of T-cells as immune players in COVID-19

Nikhil Prasad
Sep 29, 2024 3 months ago

Texas scientist warns of new SARS-CoV-2 neuroinvasion pathway involving the trigeminal nerve

Nikhil Prasad
Sep 26, 2024 3 months ago

Researchers warn that SARS-CoV-2 can infect the Meibomian glands of the eyes

Nikhil Prasad
Jul 26, 2024 5 months ago

SARS-CoV-2 spike protein accelerates aging of blood vessels

Nikhil Prasad
Jul 23, 2024 5 months ago

Forget about the KP.3, LB.1, KP.2.3 variants. The new SARS-CoV-2 KP.3.1.1 is leading the current global COVID-19 surge

Nikhil Prasad
Jul 21, 2024 5 months ago

SARS-CoV-2 Causes ACE2 Downregulation and Unique Fibrosis That Contribute to Long COVID-19

Nikhil Prasad
Jun 28, 2024 6 months ago

COVID-19 and Stroke: New Insights on Inflammation and Recovery

Nikhil Prasad
Jun 22, 2024 6 months ago

Herbs And Phytochemicals: Oleuropein From Olive Leaf Can Help Against Colorectal Cancer

Nikhil Prasad
Jun 15, 2024 6 months ago

COVID-19 News: Researchers Warn That SARS-CoV-2 Infections Can Lead To Splenic Infarctions!

Nikhil Prasad
Dec 14, 2023 1 year ago

BREAKING COVID-19 News! SARS-CoV-2 Affects Red Blood Cell Morphology!

Nikhil Prasad
Oct 04, 2023 1 year ago

Study Shockingly Shows That Many Exposed To The SARS-CoV-2 Omicron Variant Exhibit Hematuria And Proteinuria! Early Signs Of Possible Kidney Damage?

COVID-19-News-Omicron-Hematuria-Proteinuria-Kidney-Damage
May 30, 2023 2 years ago

Phenolic Phytochemicals From The Roselle Plant Or Hibiscus Sabdariffa (Thai: Krachiap กระเจี๊ยบ) Can Treat And Prevent Obesity

Herbs And Phytochemicals - Roselle - Obesity
Mar 08, 2023 2 years ago

COVID-19 News: Will SARS-CoV-2 Infections Ultimately Lead To An Increased Incidence Of Head And Neck Cancers?

COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023 2 years ago

Study Validates Previous Findings That SARS-CoV-2 Reinfections Are Now Occurring At Shorter Intervals. Current CDC and ECDC Reinfection Definitions Are Obsolete!

Source: Medical News - SARS-CoV-2 Reinfections - Omicron
Sep 28, 2022 2 years ago

Quercetin Emerging As One Of The Must Take COVID-19 Supplements Especially When Considering The Omicron Variant And Long COVID-19 Issues

Source: COVID-19 Supplements - Quercetin
Jan 02, 2022 3 years ago

BREAKING! New International Study Warns That SARS-CoV-2 Infections Will Lead To Cancers Especially Colorectal Cancers Due to Disruption In Autophagy!

Source: SARS-CoV-2-Cancer
Nov 18, 2021 3 years ago

BREAKING! COVID-19 Genetics: Yale Scientist Identify Eight ‘Super’ Genetic Variants In White People That Increases COVID-19 Death Risk!

Source: COVID-19 Genetics
Nov 13, 2020 4 years ago

Japanese Study Shows That Ozone Water Rapidly Inactivates SARS-Cov-2 Coronavirus, Making It An Ideal COVID-19 Disinfectant And Sanitizer

Source: Ozone Water-COVID-19
Nov 05, 2020 4 years ago

BREAKING NEWS! COVID-19 Study Reveals That SARS-CoV-2 Uses CD4 Cells To Infect T-helper Lymphocytes. COVID-19 A Potent Version Of Airborne HIV?

Source: BREAKING NEWS
Sep 30, 2020 4 years ago

COVID-19 News: Emerging Studies Shows SARS-CoV-2 Attacks The Digestive Tract Especially The Intestines Directly, Reported Case Of Bowel Perforation

Source: COVID-19 News
Sep 21, 2020 4 years ago

BREAKING NEWS! Study Of COVID-19 Recovered Patients In China Reveals That Lymphocytes Are Drastically Altered To Become Dysfunctional With Immunity Implications

Source: COVID-19 Recovered Patients
Jul 02, 2020 5 years ago

Occulus Hirsutus and AQCH: India Discreetly Developing And Testing COVID-19 Drug Based On Phytochemicals Extracted From Occulus Hirsutus Plant

Source: Occulus Hirsutus and AQCH
Jun 27, 2020 5 years ago

High-Flow Nasal Cannula: For COVID-19 Second Wave Preparations, Forget About Ventilators, Doctors Are Now Turning To High-Flow Nasal Cannula

Source: High-Flow Nasal Cannula
Jun 25, 2020 5 years ago

BREAKING! Androgens: Study Shows Bald Men Mostly Likely To Suffer Severe COVID-19 Conditions Due To High Levels Of Androgens

Source: Androgens And COVID-19
Jun 23, 2020 5 years ago

BREAKING NEWS! COVID-19 Research Shows That SARS-CoV-2 Coronavirus Can Survive In Water For Up To 25 Days And Could Also Be Water-Borne

Source: COVID-19 Research
Jun 23, 2020 5 years ago

BREAKING! Hepatitis B: UAE COVID-19 Case Study Indicates That COVID-19 Could Induce Hepatitis B Virus Reactivation

Source: Hepatitis B and COVID-19
Jun 21, 2020 5 years ago

BREAKING! COVID-19 Research: Sodium Channels Could Be Affected As Coronavirus Spike Protein Has Similar Sequence To Human Epithelial Sodium Channel

Source: COVID-19 Research
Jun 21, 2020 5 years ago

BREAKING! Cannabis And COVID-19: Caflanone, A Flavonoid Extracted From A Distinct Cannabis Strain Could be A Therapeutic Drug Against the COVID-19

Source: Cannabis And COVID-19
Jun 20, 2020 5 years ago

Gargling: New Studies Show That Throat Gargling May Be Beneficial After All During COVID-19 Despite Being Labeled In the Past As Misinformation

Source: Gargling and COVID-19
Jun 19, 2020 5 years ago

BREAKING! COVID-19 Research: New Study Reveals That SARS-CoV-2 Coronavirus Also Affects Thyroid Functions In Majority Of COVID-19 Patients

Source: COVID-19 Research
Jun 17, 2020 5 years ago

Exploring Inhaled Nitric Oxide (iNo) As As An Adjuvant COVID-19 Treatment For Pulmonary Issues

Source: Nitric Oxide and COVID-19
Jun 15, 2020 5 years ago

Understanding The Differences Between COVID-19 Asymptomatic and Presymptomatic Conditions

Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020 5 years ago

Scripp Institute Has Detected The Mutation That Most Scientist Dread: The D614G Mutation Which Could Make The SARS-CoV-2 More Infectious

Source: SARS-CoV-2 Mutations
Jun 13, 2020 5 years ago

BREAKING! Medical Experts Warn That COVID-19 Could Trigger Diabetes In Otherwise Healthy Individuals Who Never Had The Condition Before.

Source: Diabetes and COVID-19
Jun 13, 2020 5 years ago

Acute Pancreatitis: Warning That Acute Pancreatitis Is Now Manifesting In COVID-19 Patients, A Condition Never Seen In Early Stages Of The Pandemic

Source: Acute Pancreatitis
Jun 11, 2020 5 years ago

Immune Health: Cistanche And Pu-erh Tea Supplements Could Help Improve Immune Factors And Reduce Pro-inflammatory Cytokines Such As Interleukin-6

Source: Immune Health
Jun 09, 2020 5 years ago

Study Finds That COVID-19 Also Causes Myocardial Injury (Heart Damage)

Source: Myocardial Injury
Jun 09, 2020 5 years ago

European COVID-19 Research Indicates That Individuals With Blood Group Type A Might Be More Vulnerable To Respiratory Failure

Source: COVID-19 Research
Jun 08, 2020 5 years ago

Supplements: Singaporean Researchers Say That Vitamin D, Magnesium And Vitamin B12 Combo May Reduce Severity In Older COVID-19 Patients

Source: Supplements And COVID-19
Jun 06, 2020 5 years ago

MUST READ! Strokes: Study Shows COVID-19 Increases Risk Of Strokes In Healthy Young Individuals. Global Increase In Stroke Deaths Last Few Months

Source: Strokes And COVID-19
Jun 05, 2020 5 years ago

BREAKING ALERT! COVID-19: Italian Researchers Discover Brain Lesions On COVID-19 Patients

Source: COVID-19
May 23, 2020 5 years ago

FROM MEDICAL SCHOLARSHIPS / GRANTS

LATEST ON EVENTS

World COVID-19 News

COVID-19 Diagnostics

COVID-19 Drugs

COVID-19 Supplements

COVID-19 Herbs

COVID-19 Disinfectants

COVID-19 Mutations

COVID-19 Research

COVID News

Long COVID

COVID-19 Vaccines

COVID-19 Clinical Care

Medical Press Releases

Medical Innovations & Startups

AI in Medicine

Thailand Biotech News

Medical Spheres Bulletins

Medical White Papers

Medical Packages

Medical Tips

Medical Support Groups

MOST READ

Interesting Reads

FROM MEDICAL SCHOLARSHIPS / GRANTS

LATEST ON EVENTS